 Cymabay Therapeutics, Inc. NASDAQ:CBAY Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Paul Quinlan - General Counsel, Chief Compliance Officer Corporate Secretary Sujal Shah - President, CEO Director Charles McWherter - SVP Chief Scientific Officer Daniel Menold - VP, Finance Lewis Stuart - Chief Commercial Officer Dennis Kim - Chief Medical Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Co. Steven Seedhouse - Raymond James Associates Thomas Yip - H.C. Wainwright Co. Mayank Mamtani - B. 